Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 16.63p
   
  • Change Today:
      0.000p
  • 52 Week High: 23.75
  • 52 Week Low: 13.50
  • Currency: UK Pounds
  • Shares Issued: 132.32m
  • Volume: 8,883
  • Market Cap: 22.00m
  • RiskGrade: 179

Evgen Pharma Overview

Evgen Pharma is in the pharma and biotech sector and is currently trading at 16.63p per share. In the last year Evgen Pharma's share price has ranged from 13.50p to 23.75p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 10.6  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Evgen Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-15 n/a (2.30) (7.79)p n/a n/a n/a n/a 0.0%
31-Mar-16 n/a (3.22) (6.29)p n/a n/a n/a n/a 0.0%
31-Mar-17 n/a (3.64) (4.19)p n/a n/a n/a n/a 0.0%
31-Mar-18 n/a (3.03) (3.28)p n/a n/a n/a n/a 0.0%
31-Mar-19 n/a (3.12) (2.74)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Evgen Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-20 n/a (3.30) (2.10)p n/a n/a n/a n/a 0.0%
31-Mar-21 n/a (3.20) (1.90)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Evgen Pharma Company Announcements

Grant of further European patent 07-Aug-2019 07:00 RNS
Grant of Options 25-Jul-2019 13:00 RNS
Result of AGM 18-Jul-2019 15:47 RNS

Latest Evgen Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 16.63p
Change Today 0.000p
% Change 0.00 %
52 Week High 23.75
52 Week Low 13.50
Volume 8,883
Shares Issued 132.32m
Market Cap 22.00m
RiskGrade 179

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
52.47% below the market average52.47% below the market average52.47% below the market average52.47% below the market average52.47% below the market average
26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average26.67% below the sector average
Price Trend
14.23% below the market average14.23% below the market average14.23% below the market average14.23% below the market average14.23% below the market average
11.48% above the sector average11.48% above the sector average11.48% above the sector average11.48% above the sector average11.48% above the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 16-Aug-2019

Time Volume / Share Price
16:09 8,777 @ 16.54p
11:00 6 @ 16.54p
08:00 100 @ 16.50p

Evgen Pharma Key Personnel

CEO Stephen Franklin
CFO Richard Moulson

Top of Page